Latest Headlines

  1. GoMeyra LIMS Adds New Laboratory Test Panels Including Monkeypox 9/28/2022

    GoMeyra, a cloud-based SaaS company dedicated to providing innovative, real-time software for the health care industry, has expanded its innovative GoMeyra LIMS platform.

  2. Advanced Instruments Introduces Solentim VIPS™ PRO, A High Efficiency Single Cell Seeder To Optimize Cell Line Development Workflows 9/28/2022

    Advanced Instruments today announced the launch of Solentim VIPS PRO, a high efficiency single cell seeder, at the BioProcess International Conference in Boston, Massachusetts.

  3. Eurofins Genoma Announces Launch Of niPGT-A, A Non-Invasive, Embryo Biopsy Free, Preimplantation Genetic Aneuploidy Screening Test 9/28/2022

    Eurofins Genoma, part of the Eurofins network of companies, and a diagnostic partner for genetic, cytogenetic and molecular analyses, and one of the most advanced European molecular diagnostics laboratories, announces the launch of niPGT-A, a non-invasive preimplantation genetic aneuploidy screening test.

  4. P4 Diagnostix® Partners With Pierian To Launch Somatic Testing 9/28/2022

    P4 Diagnostix®, a network of nationally recognized laboratories ("P4"), will be partnering with Pierian, a global leader in advanced clinical genomics technology and services, to launch somatic testing for prostate cancer patients.

  5. AAV5 DetectCDx™ Kit Is First ARUP Test Developed To Support A New Therapy 9/27/2022

    The European Commission's approval of a novel gene therapy for severe hemophilia A has paved the way for use of a companion diagnostic in the European Union (EU).

  6. Hamilton And BioFluidica Pen Next Generation Liquid Biopsy Platform Co-Marketing Agreement 9/27/2022

    Biofluidica, Inc., and Hamilton Company, today announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories worldwide. Biofluidica has developed the next-generation liquid biopsy platform, enabling Hamilton liquid handlers (Microlab® STAR™ and STARlet™) to process biological samples to isolate extremely rare circulating tumor cells (CTCs), circulating Leukemic cells (CLCs), fetal cells, cfDNA, and exosomes.

  7. Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform With First Products Targeting Detection Of HPV And SARS-CoV-2 9/26/2022

    Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW™ line, a breakthrough RNA gene expression platform powered by Enzo’s LoopRNA™ in situ hybridization technology.

  8. MGI Launches Ultra High Speed DNBSEQ-G99 Gene Sequencer* With Mid To Low Range Throughput 9/26/2022

    MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput.

  9. BD, CerTest Biotec Announce US Commercial Launch Of Monkeypox Assay 9/26/2022

    BD (Becton, Dickinson and Company) ( NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories.

  10. Bionano Genomics Announces Launch Of CLIA-Certified Bionano Laboratories, And Expands Its Clinical Testing Menu With Launch Of First OGM-Based LDT For FSHD 9/23/2022

    Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen, and the launch of Bionano Laboratories’ first OGM-based laboratory developed test (LDT).